Insight

Gabriella Schivardi: Our study on the impact of molecular classes in stage IIIC endometrial cancer

Photo from Gabriella Schivardi/X

Aug 20, 2024, 13:21

Gabriella Schivardi: Our study on the impact of molecular classes in stage IIIC endometrial cancer

Gabriella Schivardi, Visiting Research Fellow of Department of Gynecology at Mayo Clinic, shared on X about a recent paper titled “Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study” published in BMJ Journals.

Authors: Gabriella Schivardi, Giuseppe Caruso, Luigi De Vitis, Giuseppe Cucinella, Francesco Multinu, Vanna Zanagnolo, Glauco Baiocchi, Louise De Brot, Tommaso Occhiali, Giuseppe Vizzielli, Robert Giuntoli, Angela Fought, Michaela McGree, Maryam Shahi, Andrea Mariani, Gretchen Glaser

Our study

“Just published online our study exploring the impact of molecular classes in stage IIIC endometrial cancer patients!”

Source: Gabriella Schivardi/X

Andrea Mariani Angela Fought cancer Francesco Multinu Gabriella Schivardi Giuseppe Caruso Giuseppe Cucinella Giuseppe Vizzielli Glauco Baiocchi Gretchen Glaser IJGC IJGC Fellows Louise De Brot Luigi De Vitis Maryam Shahi Michaela McGree OncoDaily Oncology Robert Giuntoli Tommaso Occhiali Vanna Zanagnolo

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage